Background: Pharmacovigilance is a cornerstone of the healthcare system. As patients are the end users, their contribution to such programs is inevitable. The National Pharmacovigilance Program of India emphasizes the same and this study has been conducted in the light of these findings. The study aims to ascertain public opinion, knowledge, and awareness regarding pharmacovigilance. Methods: A cross-sectional study was conducted using a validated questionnaire in the form of an online and offline survey of the general population. A convenience sampling technique was used and data collection and analysis were done. Results: Amongst the total 663 responses - 89% knew that drugs can have both beneficial and adverse effects, yet only 54% of them were aware of various drug adverse effects. A meagre 1% and 5% were aware of reporting them to the Adverse Event Monitoring Centre and banned drugs respectively. About 60% of participants believe that reporting adverse reactions is the responsibility of medical personnel only. Factors like lower education status, and rural setting were statistically significantly associated with study aspects like -lesser ADR reporting and poor knowledge of banned drugs. Conclusion: The general population needs sensitization as regards ADR reporting and pharmacovigilance given patient safety and healthcare empowerment.
No takes yet. Share an insight, caveat, or question.
Aher et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: